J Urol. 2015 Apr 1. pii: S0022-5347(15)03647-2. doi: 10.1016/j.juro.2015.03.107
Abstract
PURPOSE:
We review the current literature regarding urological management of spina bifida from prenatal diagnosis to adulthood.
MATERIALS AND METHODS:
We searched MEDLINE, EMBASE and PubMed for English articles published through December 2014 using search terms "spina bifida," "spinal dysraphism"
and "bladder." Based on review of titles and abstracts, 437 of 1,869
articles were identified as addressing topics related to open spina bifida in pediatric patients, or long-term or quality of life outcomes in adults with spina bifida. We summarize this literature to inform clinical guidelines and create a framework for disease management.
RESULTS:
The birth prevalence of spina bifida
in the United States has recently plateaued at approximately 30 per
100,000. With improved management more individuals are surviving to
adulthood, with an economic impact of $319,000 during the lifetime of an
individual with spina bifida. Recent advances in prenatal surgery have demonstrated that prenatal closure of spina bifida
is possible. To assess safety and efficacy, the National Institutes of
Health sponsored MOMS (Management of Myelomeningocele Study) was
undertaken, in which subjects were randomized to prenatal or postnatal
closure. Until the urological results of this trial are published, the
impact of prenatal intervention on future bladder function remains
unclear. Controversy continues regarding the optimal use and timing of
urodynamic studies, and the indications for initiation of clean
intermittent catheterization and anticholinergics in infants and
children. Many favor expectant management, while others argue for a more
proactive approach. Based on the current literature, both approaches
appear to protect the child from renal injury, although delayed
intervention may increase rates of bladder augmentation. The current
literature regarding this topic is difficult to interpret and compare
due to heterogeneity of patient populations, variable outcome measures
and lack of reporting of quality of life outcomes. Surgical intervention
is indicated for those at risk for renal deterioration and/or is
considered for children who fail to achieve satisfactory continence with
medical management. Traditionally surgery concentrates on 3 areas, ie
bladder and bladder neck, and creation of catheterizable channels. For
those with a hostile bladder enterocystoplasty remains the gold standard
for bladder augmentation, although use of bowel for augmentation
remains suboptimal due to secondary complications, including increased
risk of infections, metabolic abnormalities, neoplastic transformation
and risk of life threatening perforation. Recent advances in tissue
engineering technology may provide an alternative to traditional
augmentation. However, recent results from phase II trials using current
techniques to augment the bladder with engineered bladder tissue are
disappointing. Catheterizable channels to the bladder and ascending
colon further facilitate continence measures and promote independent
care. While surgical reconstruction is clearly successful in improving
continence, recent outcome studies have questioned the true impact of
this type of surgery on quality of life. With improved survival
transitional care issues, including health related independence, sexual
health needs and development of a support system, are increasingly
important. Transitional care remains a significant issue for which few
public health measures are being quantitatively evaluated.
CONCLUSIONS:
Despite consensus regarding early urological involvement in the care of patients with spina bifida,
controversy remains regarding optimal management. Major reconstructive
urological surgeries still have a major role in the management of these
cases to protect the upper urinary tract and to achieve continence.
However, future studies are needed to better clarify the true impact on
quality of life that these interventions have on patients and their
families. Transition of urological care to adulthood remains a major
avenue for improvement in disease management.
Copyright © 2015 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
KEYWORDS:
disease management; meningomyelocele; spinal dysraphism; urinary bladder